ASPIRIN
Clinical trials for ASPIRIN explained in plain language.
Never miss a new study
Get alerted when new ASPIRIN trials appear
Sign up with your email to follow new studies for ASPIRIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: ASPIRIN
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Daily aspirin during pregnancy may prevent Life-Threatening complications
Prevention Recruiting nowThis study tests whether taking 150 mg of aspirin daily, starting before the 20th week of pregnancy, can prevent serious problems like preeclampsia, poor fetal growth, placental abruption, preterm birth, and death in pregnant women with chronic high blood pressure. About 500 preg…
Matched conditions: ASPIRIN
Phase: PHASE3 • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Prevention
Last updated May 26, 2026 06:09 UTC
-
Can a different aspirin dose better protect diabetic hearts?
Knowledge-focused Recruiting nowThis study looks at how well different doses and forms of aspirin work in people with type 2 diabetes. About 30 participants will first take a standard dose of coated aspirin. Those whose blood platelets are not fully blocked will then try three other aspirin regimens to see whic…
Matched conditions: ASPIRIN
Phase: PHASE1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC